Cardiothoracic surgeon Timothy W. Mullett was named chair-elect of the Commission on Cancer of the American College of Surgeons during the CoC’s annual meeting Oct. 27 in San Francisco.
In the absence of the federal funding, cancer research will be leaning on private funders. But few private funders have the freedom to ask fundamental questions—questions whose answers may not have an immediate clinical impact but can dramatically advance scientific knowledge.
